|02-11-2019 01:23 PM CET - Health & Medicine||
Pruritus Therapeutics Market Size Worth $17,275.12 Million by 2026 | Key Industry Players - Allergan Inc., Amgen Inc., Astellas Pharma Inc.
Press release from: Polaris Market Research & Consulting
Pruritus Therapeutics Market is anticipated to reach over USD 17,275.12 Million by 2026. Pruritus, also known as itch disorder can be triggered by several ailments ranging from dermatological disorders such as mycoses, atopic dermatitis, chickenpox, and contact dermatitis, Pruritus is interrelated with the dermatologic and systemic causes. A typical itching generally forms the diagnosis of a key dermatologic syndrome. Several skin diseases that are related to pruritus include renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus. Renal pruritus can befall in people with chronic renal failure. Increased levels of ions such as calcium, phosphate, and magnesium are found in the skin of pruritic patients. Severe pruritus leads to scratching that causes secondary skin problems such as eczematization, dryness, infection, excoriation, Contact allergy, and lichenification.
Request for sample report of pruritus therapeutics market: bit.ly/2GlRHfr
The rising incidence of dermatological disorder influencing the occurrence of pruritus and subsequently, the rising demand for proper diagnostics as well as therapeutics to treat the such medical condition is anticipated to bolster the market growth. The rise in inorganic development strategies is recognized as one of the key factor boosting the growth of the pruritus therapeutic market. In addition, the key players of the pruritus therapeutic market are progressively adapting the growth strategies such as partnerships, regional acquirements, and mergers and acquisitions. Such growth strategies are anticipated to result in technological advancement owing to enhancement in the product portfolio and mutual collaboration in R&D further boosting the market growth.
The global Pruritus Therapeutics Market is segmented on the basis of product, disease type, and geography. On the basis of product, the global Pruritus Therapeutics Market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others. In 2017, the corticosteroids are expected to dominate the market by product segment as corticosteroids are widely used as the first line of treatment. On the basis of disease type, the global Pruritus Therapeutics Market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others. In 2017, Allergic contact dermatitis is estimated to dominate the market segment. It is the 3rd most general cause for patients seeking consultation with a dermatology specialist. Allergic contact dermatitis is commonly observed in women.
Browse research report on pruritus therapeutics market: bit.ly/2WWedAB
On the basis of region, the global Pruritus Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global pruritus therapeutics market. The dominance is majorly due to The presence of favorable government initiatives and the introduction of new products. Moreover, rising incidence of target disorders and the existence of pruritus inducing climatic disorders in this region are anticipated to boost the market growth during the forecast period. However, Asia Pacific is anticipated to dominate the global Pruritus Therapeutics Market. Growing incidence of atopic dermatitis and urticarial and presence of unmet healthcare organization needs are the factors attributed to the growth of the market in Asia Pacific.
Make an inquiry before buying of pruritus therapeutics market: bit.ly/2thRba0
Pruritus Therapeutics Market Top Key Player:
Astellas Pharma Inc.
Teva Pharmaceutical Industries Ltd.
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
Corporate Sales, USA
Polaris Market Research
This release was published on openPR.
News-ID: 1576987 • Views: 157More releases